Fangjian Zhou (Zhiyong Li)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Venues

BJU international

Cancer medicine

Cancer science

This page only lists publications with an associated author ORCID identifier.

Publications

Xin An, Cong Xue, Meiting Chen, Mengqian Ni, Huali Ma, Li Tian, Riqing Huang, Xiangdong Li, Yun-Lin Ye, Tao Qin, Pei Dong, Fangjian Zhou, Jing Peng, Kai Yao, Fangjian Zhou, Zhuo-Wei Liu, Yanxia Shi
Gemcitabine/Nab-Paclitaxel versus Gemcitabine/Carboplatin for Advanced Urothelial Carcinoma. BJU international (2023)
Ru Yan, Huali Ma, Lijuan Jiang, Shengjie Guo, Yanxia Shi, Xinan Sheng, Yijun Zhang, Philippe E Spiess, Tingyu Liu, Ting Xue, Xiaofeng Chen, Fangjian Zhou, Xin An, Kai Yao, Fangjian Zhou, Hui Han
First-line programmed death receptor-1 (PD-1) inhibitor and epidermal growth factor receptor (EGFR) blockade, combined with platinum-based chemotherapy, for stage IV penile cancer. BJU international (2022)
Zeshen Wu, Yu-Lu Peng, Longbin Xiong, Jun Wang, Zhen Li, Kang Ning, Minhua Deng, Ning Wang, Wensu Wei, Fangjian Zhou, Pei Dong, Chunping Yu, Fangjian Zhou, Zhiling Zhang
Role of Sam68 in Sunitinib induced renal cell carcinoma apoptosis. Cancer medicine 11 (19) (2022)
Fangjian Zhou, Lijuan Jiang, Zhiling Zhang, Minhua Deng, Wensu Wei, Huancheng Tang, Sheng-Jie Guo, Yunlin Ye, Kai Yao, Zhuo-Wei Liu, Fangjian Zhou
Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system. Cancer medicine (2021)
Zhiyong Li, Shengjie Guo, Zhiming Wu, Hui Han, Zaishang Li, Yanjun Wang, Jieping Chen, Chuangzhong Deng, Zike Qin, Zhuowei Liu, Yonghong Li, Dong Chen, Fangjian Zhou, Kai Yao
Proposal for reclassification of N staging system in penile cancer patients, based on number of positive lymph nodes. Cancer science 109 (3) (2018)

Fangjian Zhou.css-eqlu8i{font-size:small;padding-left:4px;} (Zhiyong Li)

Publication Activity (10 Years)

Top Topics

Top Venues

Fangjian Zhou (Zhiyong Li)